Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2014 1
2015 1
2017 1
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials.
Cao H, Wu R, Han M, Caldwell PHY, Liu JP. Cao H, et al. PLoS One. 2017 Jul 18;12(7):e0180746. doi: 10.1371/journal.pone.0180746. eCollection 2017. PLoS One. 2017. PMID: 28719639 Free PMC article. Review.
BACKGROUND: About 85.3% of hemolytic disease of the newborn (HDN) is caused by maternal-fetal ABO blood group incompatibility. ...CRD42016038637).Six databases were searched from inception to April 2016. Randomized controlled trial …
BACKGROUND: About 85.3% of hemolytic disease of the newborn (HDN) is caused by maternal-fetal A …
Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
Gottstein R, Cooke RW. Gottstein R, et al. Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F6-10. doi: 10.1136/fn.88.1.f6. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 12496219 Free PMC article. Review.
OBJECTIVES: To assess the effectiveness of high dose intravenous immunoglobulin (HDIVIG) in reducing the need for exchange transfusion in neonates with proven haemolytic disease due to Rh and/or ABO incompatibility. To assess the effectiveness of HDIVIG in reducing …
OBJECTIVES: To assess the effectiveness of high dose intravenous immunoglobulin (HDIVIG) in reducing the need for exchange transfusion in ne …
Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
Louis D, More K, Oberoi S, Shah PS. Louis D, et al. Arch Dis Child Fetal Neonatal Ed. 2014 Jul;99(4):F325-31. doi: 10.1136/archdischild-2013-304878. Epub 2014 Feb 10. Arch Dis Child Fetal Neonatal Ed. 2014. PMID: 24514437 Review.
CONCLUSIONS: Efficacy of IVIg is not conclusive in Rh haemolytic disease of newborn with studies with low risk of bias indicating no benefit and studies with high risk of bias suggesting benefit. Role of IVIg in ABO disease is not clear as studies that …
CONCLUSIONS: Efficacy of IVIg is not conclusive in Rh haemolytic disease of newborn with studies with low risk of bias indicat …
Immunoglobulin for alloimmune hemolytic disease in neonates.
Zwiers C, Scheffer-Rath ME, Lopriore E, de Haas M, Liley HG. Zwiers C, et al. Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD003313. doi: 10.1002/14651858.CD003313.pub2. Cochrane Database Syst Rev. 2018. PMID: 29551014 Free PMC article. Review.
Because of the risks and burdens of exchange transfusion, intravenous immunoglobulin (IVIg) has been suggested as an alternative therapy for alloimmune hemolytic disease of the newborn (HDN) to reduce the need for exchange transfusion. OBJECTIVE …
Because of the risks and burdens of exchange transfusion, intravenous immunoglobulin (IVIg) has been suggested as an alternative therapy for …
Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
Ayenew AA. Ayenew AA. Matern Health Neonatol Perinatol. 2021 Feb 2;7(1):8. doi: 10.1186/s40748-021-00129-3. Matern Health Neonatol Perinatol. 2021. PMID: 33531050 Free PMC article. Review.
BACKGROUND: Transplacental or fetomaternal hemorrhage (FMH) may occur during pregnancy or at delivery and lead to immunization to the D antigen if the mother is Rh-negative and the baby is Rh-positive. This can result in hemolytic disease of the fetus and newborn …
BACKGROUND: Transplacental or fetomaternal hemorrhage (FMH) may occur during pregnancy or at delivery and lead to immunization to the D anti …
Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis.
Olusanya BO, Osibanjo FB, Slusher TM. Olusanya BO, et al. PLoS One. 2015 Feb 12;10(2):e0117229. doi: 10.1371/journal.pone.0117229. eCollection 2015. PLoS One. 2015. PMID: 25675342 Free PMC article. Review.
The pooled data showed that primiparity (OR, 1.59; 95% CI:1.26-2.00), delivery outside public hospitals (OR, 6.42; 95% CI:1.76-23.36), ABO incompatibility (OR, 4.01; 95% CI:2.44-6.61), Rhesus hemolytic disease (OR, 20.63; 95% CI:3.95-107.65), G6PD deficiency …
The pooled data showed that primiparity (OR, 1.59; 95% CI:1.26-2.00), delivery outside public hospitals (OR, 6.42; 95% CI:1.76-23.36), AB …
Single versus double volume exchange transfusion in jaundiced newborn infants.
Thayyil S, Milligan DW. Thayyil S, et al. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004592. doi: 10.1002/14651858.CD004592.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054210 Review.
Most commonly, exchange transfusions are used in infants with rhesus hemolytic disease. OBJECTIVES: To compare the effectiveness of single volume exchange transfusion (SVET) with that of double volume exchange transfusion (DVET) in producing survival without disabil …
Most commonly, exchange transfusions are used in infants with rhesus hemolytic disease. OBJECTIVES: To compare the effectivene …
Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS, Liley H. Alcock GS, et al. Cochrane Database Syst Rev. 2002;(3):CD003313. doi: 10.1002/14651858.CD003313. Cochrane Database Syst Rev. 2002. PMID: 12137687 Updated. Review.
OBJECTIVES: To assess whether the use of intravenous immunoglobulin, in newborn infants with isoimmune haemolytic jaundice, is effective in reducing the need for exchange transfusion. ...SELECTION CRITERIA: All randomised and quasi-randomised controlled trials of the use o …
OBJECTIVES: To assess whether the use of intravenous immunoglobulin, in newborn infants with isoimmune haemolytic jaundice, is effect …